United States · Growth startup

Who invested in Metamark Genetics

4 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$47Mraised across 4 rounds since 2009, from 4 sources

$2.6MVenture$22MSeries B$13MSeries B$9.1MGrowth

Latest round: Growth, $9.1MNov 2012
Biggest round: $22MSeries B · Aug 2010
Investors: 1

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201020112012

$2.6MVenture$22MSeries B$13MSeries B$9.1MGrowth

First round: Venture, $2.6M
Biggest round: $22M
Usual gap between rounds: 2.3 years

The rounds

Nov 2012
Growth$9.1M
No investor was named in the report.
Reported by sec.govSEC filing: $9.1M sold, first sale Nov 2012
Nov 2012
Series B$13M
No investor was named in the report.
Reported by finance.yahoo.comSEC filing: $9.1M sold, first sale Nov 2012
Aug 2010
Series B$22M1 new
- Perseus
Reported by onbiovc.comSEC filing: $22M sold, first sale Jul 2010
May 2009
Venture$2.6M
No investor was named in the report.
From a historical funding recordSEC filing: $2.6M sold, first sale May 2009